Harvest Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Harvest Management’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,000	Closed	-$165K	–	71
2023 Q4	$165K	Buy	+10,000	New	+$157K	0.15%	46

Harvest Management's ORTX Position: Q1 2024 in Review

Harvest Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 10,000 shares — an estimated $165K sold.

Harvest Management first reported a position in ORTX in Q4 2023 and held it in 1 quarter. The position peaked at $165K in Q4 2023. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.

Harvest Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Harvest Management sold 10,000 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $165K.
Harvest Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2023 and held it in 1 quarter.
Harvest Management's Orchard Therapeutics plc American Depositary Shares position peaked at $165K in Q4 2023.
0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.

Based on Harvest Management's 13F filing for Q1 2024, filed 15 May 2024.